About Mainz Biomed
Mainz Biomed N.V. develops and sells in-vitro diagnostic (IVD) tests for the early detection of cancer in the United States and Europe.
It offers ColoAlert, a colorectal cancer diagnostic molecular genetic stool test. The company also develops PancAlert, a stool-based screening test for the detection of pancreatic cancer.
In addition, it operates a clinical diagnostic laboratory; and distributes its IVD kits to third-party laboratories.
The company has a collaboration agreement with Thermo Fisher Scientific Inc. for the development and commercialization of colorectal cancer screening product.
Mainz Biomed N.V. was founded in 2008 and is based in Mainz, Germany.